Comparison of the Effectiveness of Ondansetron and Domperidone in Cessation of Vomiting in Children Presenting With Acute Gastroenteritis: A Meta-Analysis.
acute gastroenteritis
domperidone
ondansetron
pediatrics
vomiting
Journal
Cureus
ISSN: 2168-8184
Titre abrégé: Cureus
Pays: United States
ID NLM: 101596737
Informations de publication
Date de publication:
Aug 2022
Aug 2022
Historique:
accepted:
03
08
2022
entrez:
8
9
2022
pubmed:
9
9
2022
medline:
9
9
2022
Statut:
epublish
Résumé
Acute gastroenteritis is one of the common diseases of childhood. Dehydration is the most frequent consequence of acute gastroenteritis, and vomiting is the most distressing clinical manifestation. Various anti-emetic agents are used in practice to control vomiting. However, not all anti-emetic agents are safe and effective. This meta-analysis aims to compare the effectiveness of ondansetron and domperidone in the cessation of vomiting in children with acute gastroenteritis. The current meta-analysis was conducted using the Preferred Reporting Items for Systematic Reviews and Meta-Analyses (PRISMA) guidelines. A comprehensive search strategy was developed to identify prospective studies that compared the effectiveness of ondansetron and domperidone in the cessation of vomiting in children with acute gastroenteritis. The primary outcome was the number of children in whom there was a cessation of vomiting. The secondary outcomes included a number of children who required an additional dose of the assigned anti-emetic and the number of children who required intravenous rehydration therapy. Overall, seven randomized trials were included in the current meta-analysis. The pooled sample size of enrolled patients was 1,262, of which 639 patients were randomized to the ondansetron group and 623 were randomized to the domperidone group. In the ondansetron group, a higher number of children experienced cessation of vomiting (risk ratio [RR]: 1.22, 95% CI: 1.08-1.37, p-value=0.002), a lower proportion of children needed an additional dose of the assigned anti-emetic (RR=0.50, 95% CI: 0.33-0.77, p-value=0.002), and a lower number of children received intravenous rehydration (RR: 0.37, 95% CI: 0.16-0.83, p-value=0.02) as compared to domperidone group. Compared to domperidone, ondansetron was found to have better efficiency in aiming cessation of vomiting in children with gastroenteritis.
Identifiants
pubmed: 36072202
doi: 10.7759/cureus.27636
pmc: PMC9438468
doi:
Types de publication
Journal Article
Review
Langues
eng
Pagination
e27636Informations de copyright
Copyright © 2022, Aisha et al.
Déclaration de conflit d'intérêts
The authors have declared that no competing interests exist.
Références
J Pediatr Gastroenterol Nutr. 2019 Apr;68(4):466-471
pubmed: 30540713
Pediatr Emerg Care. 2020 Mar;36(3):e120-e124
pubmed: 29135900
Ann Emerg Med. 2008 Jul;52(1):22-29.e6
pubmed: 18006189
MMWR Recomm Rep. 2003 Nov 21;52(RR-16):1-16
pubmed: 14627948
Paediatr Child Health. 2014 Feb;19(2):107-8
pubmed: 24596486
Aliment Pharmacol Ther. 2016 Sep;44(5):438-46
pubmed: 27401959
Pak J Med Sci. 2022 Jul-Aug;38(6):1584-1588
pubmed: 35991241
Bull World Health Organ. 2008 Sep;86(9):710-7
pubmed: 18797647
Arch Pediatr Adolesc Med. 2008 Sep;162(9):858-65
pubmed: 18762604
J Pak Med Assoc. 2018 Feb;68(2):159-164
pubmed: 29479086
Am Fam Physician. 2019 Feb 1;99(3):159-165
pubmed: 30702253
N Engl J Med. 2006 Apr 20;354(16):1698-705
pubmed: 16625009
J Clin Med Res. 2013 Dec;5(6):460-6
pubmed: 24171058
PLoS One. 2016 Nov 23;11(11):e0165441
pubmed: 27880811
Cureus. 2019 Sep 12;11(9):e5639
pubmed: 31700742